Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael P Dube Insider Profile
4 Followers
Michael P Dube, VP & CAO at Intellia Therapeutics, holds 45.64K shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Michael P Dube Sold $1,372 shares of Intellia Therapeutics on Jan 07, 2025 for an estimated value of 16.71K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+30.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
VP & CAO
Roles that Michael P Dube holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael P Dube
Michael P Dube's Trading History
List of latest transactions for each holding click on a transaction to see Michael P Dube's performance on stock
You May Also Like
Michael P Dube insider profile FAQ
What is the percentage of profitable transactions made by Michael P Dube?
The percentage of profitable transactions made by Michael P Dube is 100%.
What is the average return per transaction made by Michael P Dube?
The average return per transaction made by Michael P Dube is 30.70%.
What stocks does Michael P Dube hold?
Michael P Dube holds: NTLA stocks.
What was Michael P Dube’s latest transaction?
Michael P Dube latest transaction was an Informative Sell of $16.71K.
What was Michael P Dube's most profitable transaction?
Michael P Dube’s most profitable transaction was an Informative Sell of NTLA stock on October 4, 2024. The return on the trade was 43.30%.
What is Michael P Dube's role in Intellia Therapeutics?
Michael P Dube's role in Intellia Therapeutics is VP & CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.